Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today
Pharmacology Biochemistry and Behavior · 2025-03 · 248 · 173967
DOI: 10.1016/j.pbb.2025.173967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025-03. Verfasst von Daniel P Radin und 6 weiteren Autor:innen. Beteiligte Einrichtung: RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA. Electronic address: daniel.radin@stonybrookmedicine.edu. Hauptthemen laut MEDLINE: Receptors, AMPA, Nootropic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.
Abstract (Originalsprache)
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic receptors (AMPA receptors or AMPARs) are involved in fast excitatory neurotransmission and as such control multiple important physiological processes. AMPARs also are involved in the dynamics of synaptic plasticity in the nervous system where they impact neuroplastic responses such as long-term facilitation and long-term potentiation that regulate biological functions ranging from breathing to cognition. AMPARs also regulate neurotrophic factors that are strategically involved in neural plastic changes in the nervous system. As with other major ionotropic receptors, modulation of AMPARs can have prominent effects on biological systems that can include marked tolerability issues. AMPAR potentiators (AMPAkines) are positive allosteric modulators of AMPARs which have therapeutic potential. Medicinal chemistry combined with new pharmacological findings have defined AMPAkines with favorable oral bioavailability and pharmacological safety parameters that enable clinical advancement of their therapeutic utility. AMPAkines are being investigated in patients with diverse neurological and psychiatric disorders including spinal cord injury (breathing and bladder function), cognition, attention-deficit-hyperactivity disorder, and major depressive disorder. The present discussion of this class of compounds focuses on their general value as therapeutics through their impact on synaptic plasticity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA. Electronic address: daniel.radin@stonybrookmedicine.edu.
- RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA.
- Department of Physical Therapy, University of Florida, Gainesville, FL, USA; McKnight Brain Institute, University of Florida, Gainesville, FL, USA; Breathing Research and Therapeutics Center, University of Florida, Gain…
- Laboratory of Antiepileptic Drug Discovery St. Vincent's Hospital, Indianapolis, IN, USA.
- RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA; Laboratory of Antiepileptic Drug Discovery St. Vincent's Hospital, Indianapolis, IN, USA; Faculty of Medicine, University of Ljubljana, Zaloška cesta 4, Ljubljana, Slo…
- RespireRx Pharmaceuticals Inc., Glen Rock, NJ, USA; Laboratory of Antiepileptic Drug Discovery St. Vincent's Hospital, Indianapolis, IN, USA; Department of Neurosciene and Trauma Research, Ascension St. Vincent Hospital…
Förderung
- NINDS NIH HHS
Zitieren
APA
Radin, D. P., Lippa, A., Rana, S., Fuller, D. D., Smith, J. L., Cerne, R., & Witkin, J. M. (2025). Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today. Pharmacology Biochemistry and Behavior, 248, 173967. https://doi.org/10.1016/j.pbb.2025.173967
Vancouver
Radin DP, Lippa A, Rana S, Fuller DD, Smith JL, Cerne R, et al. Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today. Pharmacology Biochemistry and Behavior. 2025;248:173967. doi:10.1016/j.pbb.2025.173967
BibTeX
@article{Radin2025,
author = {Radin, Daniel P and Lippa, Arnold and Rana, Sabhya and Fuller, David D and Smith, Jodi L and Cerne, Rok and Witkin, Jeffrey M},
title = {Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today},
journal = {Pharmacology Biochemistry and Behavior},
year = {2025},
volume = {248},
pages = {173967},
doi = {10.1016/j.pbb.2025.173967}
}
EUVIMED